Evolent Health (EVH) Cash from Operations (2015 - 2026)

Evolent Health has reported Cash from Operations for 12 years, with the latest figure at -$9.3 million in Q2 2026.

• On a quarterly basis, Cash from Operations rose 69.3% year-over-year to -$9.3 million in Q2 2026; TTM through Jun 2026 was $54.3 million, a 262.96% increase from a year earlier, with the FY2025 full-year figure at $38.8 million, up 107.0% from the prior year.
• Cash from Operations was -$9.3 million for Q2 2026 at Evolent Health, down from -$984000.0 in the prior quarter.
• The five-year high for Cash from Operations was $89.4 million in Q4 2023, with the low at -$57.4 million in Q1 2022.
• Average Cash from Operations over 5 years is $9.9 million, with a median of $4.7 million recorded in 2024.
• The sharpest annual moves came in 2024 and 2025: Cash from Operations soared 3174.77% in 2024, then sank 241.64% in 2025.
• Over 5 years, Cash from Operations stood at $35.7 million in 2022, then jumped by 150.4% to $89.4 million in 2023, then tumbled by 129.35% to -$26.2 million in 2024, then soared by 286.04% to $48.8 million in 2025, then plunged by 119.08% to -$9.3 million in 2026.
• The last three Cash from Operations figures came in at -$9.3 million (Q2 2026), -$984000.0 (Q1 2026), and $48.8 million (Q4 2025), per Business Quant data.